Barclays’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | – | Sell |
-47,281
| Closed | -$1.35M | – | 4554 |
|
2018
Q4 | $1.35M | Sell |
47,281
-64,909
| -58% | -$1.86M | ﹤0.01% | 1619 |
|
2018
Q3 | $3.13M | Buy |
112,190
+31,457
| +39% | +$878K | ﹤0.01% | 1416 |
|
2018
Q2 | $2.25M | Buy |
80,733
+13,989
| +21% | +$390K | ﹤0.01% | 1375 |
|
2018
Q1 | $1.66M | Sell |
66,744
-25,518
| -28% | -$634K | ﹤0.01% | 1480 |
|
2017
Q4 | $2.24M | Sell |
92,262
-304,667
| -77% | -$7.38M | ﹤0.01% | 1210 |
|
2017
Q3 | $11M | Buy |
396,929
+395,673
| +31,503% | +$10.9M | 0.01% | 545 |
|
2017
Q2 | $32K | Sell |
1,256
-12,360
| -91% | -$315K | ﹤0.01% | 3153 |
|
2017
Q1 | $365K | Buy |
13,616
+7,927
| +139% | +$212K | ﹤0.01% | 2143 |
|
2016
Q4 | $149K | Sell |
5,689
-59,124
| -91% | -$1.55M | ﹤0.01% | 2438 |
|
2016
Q3 | $1.62M | Buy |
64,813
+64,714
| +65,368% | +$1.62M | ﹤0.01% | 1171 |
|
2016
Q2 | $2K | Sell |
99
-4,622
| -98% | -$93.4K | ﹤0.01% | 3339 |
|
2016
Q1 | $66K | Sell |
4,721
-9,079
| -66% | -$127K | ﹤0.01% | 2449 |
|
2015
Q4 | $290K | Sell |
13,800
-12,938
| -48% | -$272K | ﹤0.01% | 1892 |
|
2015
Q3 | $401K | Sell |
26,738
-59,018
| -69% | -$885K | ﹤0.01% | 1823 |
|
2015
Q2 | $1.2M | Buy |
85,756
+83,909
| +4,543% | +$1.18M | ﹤0.01% | 1415 |
|
2015
Q1 | $31K | Sell |
1,847
-14,151
| -88% | -$238K | ﹤0.01% | 2955 |
|
2014
Q4 | $272K | Buy |
15,998
+13,877
| +654% | +$236K | ﹤0.01% | 2239 |
|
2014
Q3 | $27K | Sell |
2,121
-3,256
| -61% | -$41.4K | ﹤0.01% | 3288 |
|
2014
Q2 | $75K | Sell |
5,377
-15,273
| -74% | -$213K | ﹤0.01% | 2865 |
|
2014
Q1 | $248K | Buy |
20,650
+11,603
| +128% | +$139K | ﹤0.01% | 2283 |
|
2013
Q4 | $90K | Sell |
9,047
-9,108
| -50% | -$90.6K | ﹤0.01% | 3089 |
|
2013
Q3 | $236K | Buy |
18,155
+15,062
| +487% | +$196K | ﹤0.01% | 2534 |
|
2013
Q2 | $44K | Buy |
+3,093
| New | +$44K | ﹤0.01% | 3389 |
|